Ligand profile
HXP
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00305 — Glutathione reductase
Identifiers
Database identifiers and provenance.
- Ligand ID
HXP- PDB
1xan- UniProt (similar protein)
P00390- Target protein
- KP13_00305
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 87.0
- −1 ≤ LogP ≤ 5 3.20
- MW ≤ 500 Da 286.3
- LogP ≤ 5 3.20
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 87.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc2c(cc1O)Oc3cc(ccc3C2CCC(=O)O)Oc1cc2c(cc1O)Oc3cc(ccc3C2CCC(=O)O)O
InChI=1S/C16H14O5/c17-9-1-3-12-11(5-6-16(19)20)13-4-2-10(18)8-15(13)21-14(12)7-9/h1-4,7-8,11,17-18H,5-6H2,(H,19,20)InChI=1S/C16H14O5/c17-9-1-3-12-11(5-6-16(19)20)13-4-2-10(18)8-15(13)21-14(12)7-9/h1-4,7-8,11,17-18H,5-6H2,(H,19,20)
PFQGLFBMMPZYEU-UHFFFAOYSA-NPFQGLFBMMPZYEU-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02852
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand HXP →
- PDB RCSB structure 1xan →
- UniProt UniProt P00390 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “HXP”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00305.
PDB 23
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).